Company Will Test Psychedelic for Treatment of Opioid Addiction

< !DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">

Gary A. Enos, Editor

A Toronto-based company is looking to have an impact on the treatment of opioid addiction by exploring the potential of psychedelics, an area of study that to this point has seen more intense activity in the mental health field.

Mind Medicine Inc. (Mindmed) announced this week that it has acquired the drug development program for 18-MC (18-methoxycoronaridine), a synthetic derivative of the psychedelic drug ibogaine. The company is preparing ...

Continue Reading →

This Detox Drug Could Get You Hooked And Kill You

< !DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">

There is no medically approved single-dose cure for opioid addiction in the United States or anywhere alse in the world for that matter.

Those that want to quit opioids on sheer willpower alone are fighting a losing battle and are in for the hell of an experience — literally. Immediately withdrawing from an opioid or going cold turkey can make a user wish he were dead.

Once an opioid is removed, “the body ...

Continue Reading →
JR Rahn, Mindmed Co-Founder and Board Member

Mindmed Acquires Opioid Addiction Drug Candidate Based on the Natural Psychedelic Ibogaine

< !DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">

 

TORONTO, Sept. 16, 2019 /PRNewswire/ — Mind Medicine, Inc. (“Mindmed”), the leading neuro-pharmaceutical company focused on discovering and developing medicines based on psychedelics, has finalized the acquisition of the 18-MC drug development program, an anti-addictive molecule that was previously funded by the National Institute on Drug Abuse (“NIDA”). Mindmed acquired the project from Savant HWP Inc., whose leadership team of top researchers and drug developers will also ...

Continue Reading →

A Detox Drug Promises Miracles—If It Doesn’t Kill You First

< !DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">

At first, Lotsof had no desire to spend a day and a half hallucinating, so he gave the dose to a friend. A month later, his friend called in the middle of the night and told him the drug was so revolutionary that they had to “tell Congress.” Lotsof decided he had to try it himself. His first experience with the drug was unlike anything else. There were endless hours of weird ...

Continue Reading →
Page 2 of 40 12345...»
UA-77446339-1